Alpha thalassemia
Last updated 17 Jun 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Alpha thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body.
Video picks for Genetic conditionsVideo library
Description
Alpha thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body.
In people with the characteristic features of alpha thalassemia, a reduction in the amount of hemoglobin prevents enough oxygen from reaching the body's tissues. Affected individuals also have a shortage of red blood cells (anaemia), which can cause pale skin, weakness, fatigue, and more serious complications.
Two types of alpha thalassemia can cause health problems. The more severe type is known as hemoglobin Bart hydrops fetalis syndrome, which is also called Hb Bart syndrome or alpha thalassemia major. The milder form is called HbH disease.
Hb Bart syndrome is characterised by hydrops fetalis, a condition in which excess fluid builds up in the body before birth. Additional signs and symptoms can include severe anaemia, an enlarged liver and spleen (hepatosplenomegaly), heart defects, and abnormalities of the urinary system or genitalia. Without treatment, most babies with this condition are stillborn or die soon after birth because of these serious health problems. Hb Bart syndrome can also cause serious complications for women during pregnancy, including dangerously high blood pressure with swelling (preeclampsia), premature delivery, and abnormal bleeding.
HbH disease causes mild to moderate anaemia, hepatosplenomegaly, and yellowing of the eyes and skin (jaundice). The features of HbH disease usually appear in early childhood, and affected individuals typically live into adulthood.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Related genes
Other names
Alpha-thalassemia
Α-thalassemia
Patient picks for Genetic conditions

Treatment and medication
Alpha-blockers
Alpha-blockers are medicines that are mainly used to treat high blood pressure (hypertension) and problems with passing urine in men who have enlargement of the prostate gland. Prostate gland enlargement is also called benign prostatic hyperplasia (BPH).
by Dr Doug McKechnie, MRCGP

Children's health
Alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency is an inherited genetic condition. A genetic condition is one that can be passed on from parents through genes. In alpha-1 antitrypsin deficiency the result of a genetic abnormality leads to lung and, in some people, liver damage. Lung symptoms are the most common and include shortness of breath, cough and wheezing. Symptoms can worsen over time. At present, there is no cure for alpha-1 antitrypsin deficiency. Treatment aims at slowing down the progression of the disease.
by Dr Philippa Vincent, MRCGP

Medicine
Phenoxybenzamine - an alpha-blocker
Adults will normally start with one capsule a day. This dose may then be increased over the next few days. It is common to feel dizzy or light-headed initially. This should soon settle. You may be given other medicines to take alongside phenoxybenzamine.
by Michael Stewart, MRPharmS

Medicine
Alfacalcidol capsules and drops
Alfacalcidol is a type of vitamin D. You will need to have regular blood tests while you are taking the medicine so that your doctor can adjust your dose. Make sure you know the symptoms of too much calcium in your blood - these are losing your appetite, feeling thirsty, being sick (vomiting), feeling tired and losing weight. Please let your doctor know if you develop these symptoms.
by Michael Stewart, MRPharmS

Medicine
Indoramin - an alpha-blocker
Indoramin is prescribed for two different medical conditions: 20 mg strength tablets are prescribed for men with prostate problems, and 25 mg strength tablets are prescribed for people with high blood pressure. You are advised not to drink alcohol while you are on indoramin. Do not drive and do not use tools or machines if you feel tired or dizzy.
by Michael Stewart, MRPharmS

Medicine
Doxazosin - an alpha-blocker
Take doxazosin once each day. Take your first dose at bedtime. As your body is getting used to doxazosin you may feel dizzy or light-headed when standing up or sitting up quickly - getting up more slowly will help. Do not drive and do not use tools or machines if you feel tired or dizzy.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Thalassaemia
Thalassaemia is an inherited condition affecting the blood. ... The main types of thalassaemia are called alpha thalassaemia and beta thalassaemia. The more severe beta types are beta thalassaemia major (BTM) and beta thalassaemia intermedia (BTI). The more severe alpha forms are Hb Barts (very severe) and HbH disease (moderate). There are also.

Patient information leaflet
Liver failure
Diseases of the veins in the liver Some diseases (for example, Budd-Chiari syndrom... Metabolic diseases Some rare metabolic diseases may cause acute liver failure. These include haemochromatosis Haemochromatosis , alpha-1 antitrypsin deficiency Alpha-1 antitrypsin deficiency , Wilson's disease Wilson's disease , fructose intolerance,.

Patient information leaflet
Restless legs syndrome
Lack of iron (iron de. If this is the cause then the symptoms of RLS usually go if you take iron tablets. Also after a time on dopamine agonists, symptoms can suddenly become much worse. If this is the case, you will need to stop or change your medication. Alpha-2-delta ligands This is another group of recommended medicines (although they do not.

Patient information leaflet
Peripheral vasodilators
Peripheral vasodilators are medicines that are used to treat conditions that affect blood vessels in outer (peripheral) parts of the body such as the arms and legs. For example, they are used to treat peripheral arterial disease and Raynaud's phenomenon. Nifedipine Nifedipine is a type of medicine called a calcium-channel blocker. Moxisylyte is a.

Patient information leaflet
Spina bifida
Very mild forms (spinal bifida occulta), in which there are no symptoms, may never be detected. Before birth The most common screening methods used to look for spina bifida during pregnancy are the blood test for alpha-fetoprotein and an ultrasound scan, which are routinely performed at 16-18 weeks of pregnancy. See the separate leaflet called.

Patient information leaflet
COVID-19
There is also some concern that existing vaccines and treatments might be less effective against the variants. However, in some cases, they also seem to be less likely to cause serious illness. Notable variants of SARS CoV-2 include: the alpha variant; beta variant; delta variant; and omicron variant. Who is at risk of catching COVID. Anyone can.
Further reading and references
- Alpha thalassemia; MedlinePlus, National Library of Medicine.
- Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003 Feb 1;101(3):791-800. doi: 10.1182/blood-2002-07-1975. Epub 2002 Sep 12. No abstract available.
- Chui DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25-32. doi: 10.1196/annals.1345.004.
- Higgs DR, Weatherall DJ. The alpha thalassaemias. Cell Mol Life Sci. 2009 Apr;66(7):1154-62. doi: 10.1007/s00018-008-8529-9.
- Leung WC, Leung KY, Lau ET, Tang MH, Chan V. Alpha-thalassaemia. Semin Fetal Neonatal Med. 2008 Aug;13(4):215-22. doi: 10.1016/j.siny.2008.02.006. Epub 2008 Apr 10.
- Tamary H, Greenberg-Kushnir N, Dgany O. Alpha-Thalassemia. 2005 Nov 1 [updated 2026 Apr 23]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1435/
- Urbinati F, Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part II: thalassaemias. Expert Rev Mol Med. 2006 May 9;8(10):1-26. doi: 10.1017/S1462399406010805.
- Vichinsky EP. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009:35-41. doi: 10.1182/asheducation-2009.1.35.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-12. Epub 2001 Oct 24.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

